Delivery Order SPE2DB20D3111-SPE2DB24FA8JF

Award Date 7/23/24
Potential Completion Date 7/24/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,943.76 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,958.74 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract is a delivery order valued at $2,110.95 with a period of performance through September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999, for the...
The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,002.40 contract is for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with Amerisourcebergen Drug Corp as the sole prime...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,187.60 contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL insulin pens. The award has an ultimate completion date of February 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,334.60, is for the delivery of Lantus SoloStar 100 unit/mL 3mL insulin pens. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus SoloStar insulin pens. The contract, valued at $2,783.68, is a firm-fixed-price delivery order with an ultimate completion date of August 2, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $1,070.08, is for the delivery of Lantus SoloStar 100 unit/mL 3mL insulin pens. This is a firm-fixed-price delivery order contract with a completion date of September 5, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The company holds several...
The U.S. Defense Logistics Agency Troop Support Medical awarded a $3,056.53 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Lantus SoloStar 100 unit/mL 3mL insulin pens. This delivery order falls under Amerisourcebergen's larger $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The award, valued at $1,187.60, is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of medical...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB24FA8JF
    Delivery Order

This contract award to AmerisourceBergen Drug Corp for $1,174.36 was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is a delivery order for 4,565,230,539 units of Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract has no set-aside designation and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide.

Generated 10/22/24, 9:09 AM